PFE
Pfizer Inc.Healthcare · $163.4B market cap
Verdict
Share price
$27.80
close of Oct 3, 2026
Fair value
$45.59
Sticker Price
Payback Price
$18.24
buy price
PFE is Undervalued: at $27.80 it trades 39% below its fair value of $45.59. Its buy price (Payback Price) is $18.24, 34% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.
How we valued it
Dividend Discount Model. It has paid a dividend for 10+ years in a row, raised it most years, and yields over 2%. For a steady payer like this, the dividend is the best guide to value.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow PFE
Get notified when it reaches its buy price of $18.24. Free.
Create a free accountSuperinvestors
11 of the investors we track hold PFE. In Q2 2026, 1 opened a position and 2 added. Who we track
Michael Burry
Scion Asset Management LLC · as of Q3 2025
$152.9M
6,000,000 shares
Richard Pzena
Pzena Investment Management · as of Q2 2026
$143.5M
5,958,922 shares
Harry Burn
Sound Shore · as of Q2 2026
$92.0M
3,820,117 shares
Sarah Ketterer
Causeway Capital Management · as of Q2 2026
$46.2M
1,916,801 shares
Prem Watsa
Fairfax Financial Holdings · as of Q2 2026
$25.1M
1,043,900 shares
Show all 11 holdersShow fewer
Torray Funds
Torray Funds · as of Q2 2026
$20.7M
859,418 shares
Kahn Brothers Group
Kahn Brothers Group · as of Q2 2026
$13.6M
484,733 shares
Bruce Berkowitz
Fairholme Capital · as of Q2 2026
$5.6M
231,000 shares
Hillman Capital Management
Hillman Capital Management · as of Q2 2026
$4.2M
174,610 shares
Dodge & Cox Funds
Dodge & Cox Funds · as of Q2 2026
$2.1M
87,814 shares
Mairs & Power Funds
Mairs & Power Funds · as of Q2 2026
$1.6M
67,679 shares
Insider activity
Since Jun 15, 2026: 3 open-market purchases worth $3.0M, 1 sale worth $83K and 13 other filings (stock awards, tax withholding and similar). Why purchases matter
Purchases
BOURLA ALBERT
Chairman & CEO · 2026-08-12
Bought
$1.0M
Buckley Mortimer J
director · 2026-08-05
Bought
$960K
BLAYLOCK RONALD E
director · 2026-08-05
Bought
$999K
Sales
Other filings
BOURLA ALBERT
Chairman & CEO · 2026-08-31
Award
21 shares
BOURLA ALBERT
Chairman & CEO · 2026-08-14
Award
22 shares
BOURLA ALBERT
Chairman & CEO · 2026-07-31
Award
24 shares
BOURLA ALBERT
Chairman & CEO · 2026-07-15
Award
24 shares
BOURLA ALBERT
Chairman & CEO · 2026-07-09
Award
84 shares
Show all 13 other filingsShow fewer
BOURLA ALBERT
Chairman & CEO · 2026-06-30
Award
25 shares
Taraporevala Cyrus
director · 2026-06-26
Award
1,543.845 shares
Quincey James
director · 2026-06-26
Award
1,595.307 shares
SMITH JAMES C
director · 2026-06-26
Award
1,852.614 shares
NARAYEN SHANTANU
director · 2026-06-26
Award
2,058.46 shares
Echevarria Joseph
director · 2026-06-26
Award
1,904.076 shares
Buckley Mortimer J
director · 2026-06-26
Award
1,543.845 shares
BOURLA ALBERT
Chairman & CEO · 2026-06-15
Award
23 shares
About Pfizer Inc.
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small…
Drug Manufacturers - General
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works